U.S. market Open. Closes in 3 hours 23 minutes

OPT | Opthea Limited Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 3.66 - 3.86
52 Week Range 1.7900 - 5.45
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 5,482
Average Volume 31,196
Shares Outstanding 153,886,250
Market Cap 562,454,244
Sector Healthcare
Industry Biotechnology
IPO Date 2020-10-16
Valuation
Profitability
Growth
Health
P/E Ratio -1.32
Forward P/E Ratio N/A
EPS -2.76
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 33
Country Australia
Website OPT
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
*Chart delayed
Analyzing fundamentals for OPT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see OPT Fundamentals page.

Watching at OPT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on OPT Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙